Jeff Knight
Directeur des opérations chez CRINETICS PHARMACEUTICALS, INC.
Fortune : 2 M $ au 30/04/2024
Profil
Jeff E Knight is currently the Chief Operating Officer at Crinetics Pharmaceuticals, Inc. He previously worked as the Executive Director-Global Development Operations at Amgen, Inc. from 2015 to 2017, as the VP-Clinical Operations & Project Management at Onyx Pharmaceuticals, Inc. from 2012 to 2015, as the VP-Development Operations & Portfolio Management at Halozyme Therapeutics, Inc. from 2017 to 2018, and as the SVP-Portfolio Management & Corporate Operations at Poseida Therapeutics, Inc. from 2018 to 2021.
Mr. Knight received his undergraduate degree from the University of Kansas and his graduate degree from the University of Oklahoma.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2024 | 52 580 ( 0,07% ) | 2 M $ | 30/04/2024 |
Postes actifs de Jeff Knight
| Sociétés | Poste | Début |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Directeur des opérations | 30/08/2021 |
Anciens postes connus de Jeff Knight
| Sociétés | Poste | Fin |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 31/08/2021 |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2018 |
| AMGEN INC. | Corporate Officer/Principal | 01/03/2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/07/2015 |
Formation de Jeff Knight
| University of Kansas | Undergraduate Degree |
| University of Oklahoma | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
